Main info

Identifier:

HO25 NHL / OG 95-004

Sponsor:

HOVON

Stage:

1st Line

Included patients:

411

Active sites:

0

(of 52)

52 sites are pending

Title:

Effect of Recombinant G-CSF on the Results of Chemotherapy (CHOP) in Elderly Patients with Intermediate-/High-Grade Non-Hodgkin's Lymphoma: A Prospective Phase III Study.

Timeline

Flow

Details

Phase:

Prospective randomized Phase III study

Monitoring Type:

Not any more

Objectives:

Eligibility

Inclusion Criteria:

• Patients with previously untreated Non-Hodgkin's Lymphoma, Ann Arbor stages II-IV, of intermediate- or high-grade malignancy.
• Patients with age 65 years or more.
• Informed consent.

Exclusion Criteria:

• Patients aged less than 65
• Patients who have been treated for Non-Hodgkin's Lymphoma by chemotherapy or radiotherapy.
• Other malignant diseases, except localized squamous skin carcinoma.
• Severe heart failure.
• Inadequate liver or renal function.
• Failure to give informed consent.
• HIV positivity.

Registration Details

Participating Sites

= Active hospitals

= Inactive hospitals